Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
A holder of Globe Life Inc. common stock filed a notice of proposed sale of 12,500 shares under Rule 144. The shares are to be sold through Apex Clearing on the NYSE, with an aggregate market value listed as 1,801,250 and total shares outstanding of 78,580,771.
The seller acquired these 12,500 shares on the same date through a stock option exercise, with the consideration described as proceeds of the option exercise. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Globe Life’s current or prospective operations.
Globe Life Inc. executive Jennifer A. Haworth, EVP & Chief Marketing Officer, exercised an employee stock option for 10,000 shares of common stock at an exercise price of $50.64 per share on February 12, 2026. She then sold 10,000 shares of Globe Life common stock in multiple open-market transactions the same day at prices ranging from $141.595 to $144.075 per share. Following these transactions, she directly owned 17,479 shares of common stock and indirectly held 1,938.443 shares through a Thrift/401(k) Plan trust.
Globe Life Inc. has an affiliated holder filing a notice to sell 10,000 shares of its common stock under Rule 144. The shares are to be sold through APEX Clearing on the NYSE, with an aggregate market value of 1,471,000 and 78,580,771 shares outstanding. The approximate sale date given is 02/12/2026. The seller acquired the 10,000 shares on 02/09/2026 through a stock option exercise from Globe Life Inc., with payment dated 02/12/2026.
Globe Life Inc. executive vice president and chief financial officer Thomas P. Kalmbach reported acquiring 7,537 shares of Globe Life common stock on February 26, 2025 at a reported price of $0, leaving him with 25,780.945 shares beneficially owned directly after the transaction.
The amended filing states this total includes 17.136 shares acquired through the company’s dividend reinvestment plan since the last report and clarifies that the amendment was made to correct the beneficial ownership amount, which also affects one subsequent filing.
Globe Life Inc. director Mark A. Blinn reported an indirect sale of common stock through a trust. On 02/06/2026, the trust sold 1,750 Globe Life shares at $147.91 per share. After the sale, Blinn held 1,373 shares directly and 3,372 shares indirectly through the trust.
Globe Life Inc. director amends prior insider trade report to clarify ownership. The amended Form 4 shows that on January 6, 2025, a trust associated with the director sold 3,000 shares of Globe Life common stock at $113.235 per share.
After the sale, the director holds 1,604 shares directly and 3,518 shares indirectly through the trust. The amendment corrects the earlier filing to state that the transaction was executed from the reporting person's trust account rather than from a direct personal holding.
Globe Life Inc. director Mark A. Blinn reported an amended insider transaction. On 04/25/2024, a trust associated with him purchased 2,000 shares of Globe Life common stock at $76.77 per share. The amendment corrects the attribution of beneficial ownership to the reporting person’s trust.
After this transaction, the filing shows 5,043 shares of Globe Life common stock held indirectly through the trust and 1,475 shares held directly by Blinn.
Globe Life Inc. executive Michael Clay Majors, EVP and Chief Strategy Officer, reported stock option exercises and share sales dated February 6, 2026. He exercised employee stock options for 27,000 shares at $100.74 per share and 3,000 shares at $98.32 per share, receiving common stock.
On the same date he sold several blocks of common stock, including 11,581, 13,510, 3,488 and 1,421 shares at weighted average prices of about $146.04, $147.18, $147.92 and $148.63 per share, with detailed price ranges disclosed in the footnotes. After these transactions he directly owned 47,066 Globe Life shares and reported 0 shares held indirectly.
GL filed a notice of proposed sale of restricted securities under Rule 144. The filing covers the planned sale of 1,750 shares of common stock through Stifel Nicolaus & Company on the Nasdaq market with an aggregate market value of $258,843.00.
The shares relate to prior grants of restricted stock units from the issuer, with acquisitions dated July 3, 2023, April 25, 2024, and July 24, 2024. GL had 79,605,800 shares of common stock outstanding as of the figures shown, which is a baseline ownership figure rather than the amount being sold.
Globe Life Inc. received a Rule 144 notice covering a planned sale of 45,000 shares of its common stock through broker APEX Clearing on the NYSE, with an aggregate market value of $6,612,750 and an approximate sale date of 02/06/2026.
The 45,000 shares were acquired on 02/06/2026 via a stock option exercise from Globe Life Inc. Common shares outstanding were 78,637,130. The seller represents that they do not know of any undisclosed material adverse information about Globe Life’s current or prospective operations.